Cormark Has Pessimistic Outlook of STERIS’ FY2024 Earnings

Posted by on Nov 22nd, 2024

STERIS’ (TSE:STE – Free Report) – Analysts at Cormark dropped their FY2024 earnings estimates for shares of STERIS’ in a report issued on Monday, November 18th. Cormark analyst B. Watson now expects that the company will post earnings per share of $0.25 for the year, down from their previous forecast of $0.77.

STERIS’ Price Performance

STERIS’ Company Profile

(Get Free Report)

STERIS’s MISSION IS TO HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare and life science product and service solutions around the globe by providing innovative healthcare and life science product and service solutions around the globe.

Further Reading

Earnings History and Estimates for STERIS’ (TSE:STE)

Receive News & Ratings for STERIS’ Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS’ and related companies with MarketBeat.com's FREE daily email newsletter.